NorthCrest Asset Manangement’s Kura Oncology KURA Stock Holding History

NorthCrest Asset Manangement’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Buy	21,132 +3,676	+21%	+$34.7K	0.01%	778
2026 Q1	$150K	Sell	17,456 -4,406	-20%	-$37.9K	﹤0.01%	741
2025 Q4	$209K	Buy	21,862 +3,541	+19%	+$37.2K	﹤0.01%	776
2025 Q3	$173K	Buy	+18,321	New	+$131K	﹤0.01%	726
2025 Q2	–	Sell	-11,300	Closed	-$74.6K	–	646
2025 Q1	$74.6K	Buy	11,300 +788	+7%	+$6.14K	﹤0.01%	589
2024 Q4	$91.6K	Sell	10,512 -175	-2%	-$2.52K	﹤0.01%	559
2024 Q3	$209K	Buy	10,687 +187	+2%	+$3.79K	0.01%	526
2024 Q2	$216K	Hold	10,500	–	–	0.01%	489
2024 Q1	$224K	Hold	10,500	–	–	0.01%	481
2023 Q4	$151K	Hold	10,500	–	–	0.01%	500
2023 Q3	$95.8K	Hold	10,500	–	–	﹤0.01%	494
2023 Q2	$111K	Hold	10,500	–	–	﹤0.01%	492
2023 Q1	$128K	Hold	10,500	–	–	0.01%	480
2022 Q4	$130K	Hold	10,500	–	–	0.01%	385
2022 Q3	$143K	Hold	10,500	–	–	0.01%	425
2022 Q2	$192K	Hold	10,500	–	–	0.01%	420
2022 Q1	$169K	Hold	10,500	–	–	0.01%	401
2021 Q4	$147K	Buy	+10,500	New	+$170K	0.01%	396

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

OAM

OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

NorthCrest Asset Manangement's KURA Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its Kura Oncology (KURA) stake by 21% in Q2 2026, buying an estimated $34.7K and bringing the position to 21,132 shares worth $255K. The position accounts for 0.01% of the portfolio, ranked #778.

NorthCrest Asset Manangement first reported a position in KURA in Q4 2021 and has held it in 18 quarters since. 76 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

NorthCrest Asset Manangement held 21,132 shares of Kura Oncology worth $255K as of Q2 2026.
NorthCrest Asset Manangement bought 3,676 Kura Oncology shares in Q2 2026, an estimated $34.7K.
Kura Oncology made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #778 holding.
NorthCrest Asset Manangement first reported a position in Kura Oncology in Q4 2021 and has held it in 18 quarters since.
76 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.